title: Highlighting the role of polymer length, carbohydrate size, and nucleic acid type in potency of glycopolycation agents for pDNA and siRNA delivery.
abstract: While nucleic acids such as small interfering RNA (siRNA) and plasmid DNA (pDNA) are promising research tools and therapeutic modalities, their potential in medical applications is limited by a fundamental mechanistic understanding and inadequate efficiency. Herein, two series of carbohydrate-based polycations were synthesized and examined that varied in the degree of polymerization (n), one containing trehalose [Tr4(n) series: Tr4(23), Tr4(55), Tr4(77)] and the other containing β-cyclodextrin [CD4(n) series: CD4(10), CD4(26), CD4(39), CD4(143), CD4(239)]. In addition, two monosaccharide models were examined for comparison that contain tartaramidoamine (T4) and galactaramidoamine (G4 or Glycofect) repeats. Delivery profiles for pDNA were compared with those obtained for siRNA delivery and reveal that efficacy differs significantly as a function of carbohydrate type, nucleic acid type and dose, polymer length, and presence of excess polymer in the formulation. The Tr4 polymers yielded higher efficacy for pDNA delivery, yet the CD4 polymers achieved higher siRNA delivery and gene down-regulation. The T4 and Glycofect derivatives, while efficient for pDNA delivery, were completely ineffective for siRNA delivery. A strong polymer length and dose dependence on target gene knockdown was observed for all polymers tested. Also, free polymer in solution (uncomplexed) was demonstrated to be a key factor in promoting siRNA uptake and gene down-regulation.
authors.affiliation: Department of Chemistry, University of Minnesota , 207 Pleasant Street SE, Minneapolis, Minnesota 55455, United States.
authors.forename: Lian
authors.initials: L
authors.lastname: Xue
authors.forename: Nilesh P
authors.initials: NP
authors.lastname: Ingle
authors.forename: Theresa M
authors.initials: TM
authors.lastname: Reineke
mesh_terms: D045744:Cell Line, Tumor; D004247:DNA / Q000235:genetics; D018014:Gene Transfer Techniques; D006801:Humans; D008968:Molecular Conformation; D010957:Plasmids; D011073:Polyamines / Q000138:chemical synthesis / Q000737:chemistry*; D000071228:Polyelectrolytes; D058105:Polymerization; D034741:RNA, Small Interfering / Q000235:genetics; D014199:Trehalose / Q000737:chemistry*; D047392:beta-Cyclodextrins / Q000737:chemistry*
chemical_list: D004247:DNA; D011073:Polyamines; D000071228:Polyelectrolytes; D034741:RNA, Small Interfering; D014199:Trehalose; D047392:beta-Cyclodextrins; C031215:betadex
references.citation: Mol Biol Cell. 1999 Apr;10(4):961-74
references.pmid: 10198050
references.citation: Mol Pharm. 2009 May-Jun;6(3):659-68
references.pmid: 19267452
references.citation: Biomaterials. 2007 Jun;28(18):2885-98
references.pmid: 17367850
references.citation: J Am Chem Soc. 2004 Jun 23;126(24):7422-3
references.pmid: 15198572
references.citation: J Biol Chem. 1996 Jul 5;271(27):16026-34
references.pmid: 8663188
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7297-301
references.pmid: 7638184
references.citation: Bioconjug Chem. 2008 Feb;19(2):428-40
references.pmid: 18197609
references.citation: Chem Rev. 2009 Feb;109(2):259-302
references.pmid: 19053809
references.citation: Pharm Res. 2007 Aug;24(8):1590-8
references.pmid: 17385010
references.citation: Nanomedicine. 2009 Mar;5(1):8-20
references.pmid: 18640078
references.citation: Biomaterials. 2009 Feb;30(5):928-38
references.pmid: 19027153
references.citation: Adv Drug Deliv Rev. 2009 Jul 25;61(9):721-31
references.pmid: 19328215
references.citation: J Control Release. 2006 May 15;112(2):257-70
references.pmid: 16574264
references.citation: Chem Pharm Bull (Tokyo). 2009 Feb;57(2):138-43
references.pmid: 19182402
references.citation: Mol Pharm. 2012 Aug 6;9(8):2256-67
references.pmid: 22715912
references.citation: Biomacromolecules. 2011 Aug 8;12(8):3015-22
references.pmid: 21657209
references.citation: Nat Rev Drug Discov. 2009 Feb;8(2):129-38
references.pmid: 19180106
references.citation: J Control Release. 2008 Oct 21;131(2):150-7
references.pmid: 18706946
references.citation: Nanomedicine. 2011 Apr;7(2):210-9
references.pmid: 20709624
references.citation: J Gene Med. 2004 Oct;6(10):1102-11
references.pmid: 15386739
references.citation: J Am Chem Soc. 2006 Jun 28;128(25):8176-84
references.pmid: 16787082
references.citation: J Am Chem Soc. 2009 Jul 22;131(28):9843-8
references.pmid: 19555104
references.citation: Biomacromolecules. 2012 Nov 12;13(11):3463-74
references.pmid: 23020076
references.citation: Langmuir. 2008 Aug 5;24(15):8090-101
references.pmid: 18605743
references.citation: J Am Chem Soc. 2008 Apr 9;130(14):4618-27
references.pmid: 18338883
references.citation: Mol Pharm. 2009 May-Jun;6(3):651-8
references.pmid: 19115957
references.citation: Nature. 1998 Feb 19;391(6669):806-11
references.pmid: 9486653
references.citation: Nat Rev Drug Discov. 2007 Jun;6(6):443-53
references.pmid: 17541417
references.citation: J Control Release. 2012 Jul 20;161(2):554-65
references.pmid: 22123560
references.citation: J Control Release. 2012 Jun 28;160(3):532-41
references.pmid: 22465674
references.citation: Nat Rev Genet. 2001 Feb;2(2):110-9
references.pmid: 11253050
references.citation: Nat Rev Mol Cell Biol. 2003 Jun;4(6):457-67
references.pmid: 12778125
references.citation: Bioconjug Chem. 2006 Jan-Feb;17(1):101-8
references.pmid: 16417257
references.citation: J Control Release. 2012 Dec 28;164(3):380-6
references.pmid: 22732477
references.citation: Methods Mol Biol. 2010;610:201-11
references.pmid: 20013180
references.citation: J Control Release. 2012 Mar 10;158(2):261-8
references.pmid: 22119955
references.citation: J Am Chem Soc. 2005 Mar 9;127(9):3004-15
references.pmid: 15740138
references.citation: Langmuir. 2007 Sep 11;23(19):9773-84
references.pmid: 17705512